Contractor High Throughput Cellular Assays (6 Months)
Boston, NH - USA
Job Summary
Overview
Monte Rosa Therapeutics is seeking a passionate Contractor High Throughput Cellular Assays with the experience to implement and run complex cellular assays for a 6-month contract. This position is a key role in the pivotal team responsible for Automation and Screening Technologies & hits-to-leads support for Monte Rosas diverse pipeline. The ideal candidate will be able to help evolve Monte Rosas hit identification and hits-to-leads endeavors through embracing novel assay technologies enhancing overall process and actively drive internal and external partnerships.
Responsibilities
- Perform a variety of molecular and cellular biology techniques including mammalian cell culture protein purification and Western blotting
- Implement and help to execute cell-based and biochemical assays using various technologies (e.g. fluorescence luminescence TR-FRET AlphaScreen)
- Utilize automated liquid handling systems and laboratory robotics
- Analyze and interpret experimental data compile results and present findings to the team
- Maintain cell lines and prepare stock solutions
- Manage laboratory inventories and handle biohazardous materials according to safety protocols
- Ensure compliance with laboratory safety procedures and guidelines
Qualifications
- Bachelors degree or equivalent in Biochemistry Cell Biology or a life science with 1-2 years of industrial experience.
- Experience in mammalian cell line engineering (CRISPR tagging lentiviral transduction overexpression) in both adherent and suspension cell linesis a plus.
- Proven track record for striving for high level of innovation and scientific excellence.
- Flexibility to accommodate rapidly changing priorities and deadlines.
- Ability to work in a team-based environment.
- Excellent oral and written communication skills.
Required Experience:
Contract
About Company
Pioneering Therapies for Cancer and Beyond – Our drug discovery platform is tailored to promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, undruggable proteins, in essence leading to pharmacological protein knockout with high efficiency ... View more